The US Food and Drug Administration (FDA) is reminding clinicians about the need for "at least yearly, lifelong follow-up" to monitor for type III endoleaks in patients with any type of Endologix AFX ...

Major Medical Devices, Inc. (MMD), an emerging developer in vascular intervention technologies for abdominal aortic aneurysm (A ...

Nectero Medical Inc. has secured $19.5 million in a series C financing round, led by Boston Scientific Corp. The company is developing the Endovascular Aortic Stabilization Treatment (EAST) system, a ...

For the second time this year, the US Food and Drug Administration has issued a safety communication to healthcare professionals regarding risk of Type III endoleaks associated with Endologix AFX ...

Please provide your email address to receive an email when new articles are posted on . The FDA Circulatory System Devices Panel of the Medical Devices Advisory Committee voted 11-4 that the benefits ...

That women fare worse than men after treatment for abdominal aortic aneurysm isn’t news, but 10 years’ worth of US registry data show that the difference is long-lasting and appears restricted to ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Among patients with abdominal aortic ...

Abdominal aortic aneurysm, a weakening and ballooning of the aorta, the largest blood vessel in the body, may result in a life-threatening rupture. In a small, preliminary study examining a potential ...

“Abdominal Aortic Aneurysm Pipeline Insight, 2020” report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Abdominal Aortic ...

Nectero Medical Inc. has secured $19.5 million in a series C financing round, led by Boston Scientific Corp. The company is developing the Endovascular Aortic Stabilization Treatment (EAST) system, a ...